Market Closed -
Nasdaq
04:00:00 2024-05-20 pm EDT
5-day change
1st Jan Change
13.65
USD
-0.58%
-1.30%
-4.55%
Presentation Operator MessageOperator (Operator)Welcome, ladies and gentlemen, to the Fourth Q...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Transcript : Tactile Systems Technology, Inc., Q1 2024 Earnings Call, May 06, 2024
May. 06
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q1 Revenue $61.1M, vs. Street Est of $59.2M
May. 06
MT
Tactile Systems Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 06
CI
Tactile Systems Technology, Inc. Announces CEO Transition
Apr. 23
CI
Tactile Systems Technology, Inc. Provides Preliminary Revenue Guidance for the First Quarter 2024
Apr. 23
CI
Transcript : Tactile Systems Technology, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Feb. 20
Tactile Systems Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 20
CI
Tactile Systems Technology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 20
CI
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q4 Revenue $77.7M
Feb. 20
MT
Tactile Systems Technology, Inc. Provides Revenue Guidance for the Full Year 2024
Feb. 20
CI
Piper Sandler Cuts Tactile Systems Technology Price Target to $23 From $30, Maintains Overweight Rating
Nov. 07
MT
Tactile Systems Technology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 06
CI
Transcript : Tactile Systems Technology, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Nov. 06
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q3 Revenue $69.6M, vs. Street Est of $69.1M
Nov. 06
MT
Tactile Systems Technology, Inc. Updates Earnings Guidance for the Full Year 2023
Nov. 06
CI
Tactile Systems Technology, Inc. Appoints Vindell Washington as Board of Directors
23-10-01
CI
Oppenheimer Adjusts Tactile Systems Technology Price Target to $30 From $24, Maintains Outperform Rating
23-08-08
MT
Tactile Systems Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-07
CI
Transcript : Tactile Systems Technology, Inc., Q2 2023 Earnings Call, Aug 07, 2023
23-08-07
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Posts Q2 Revenue $68.3M, vs. Street Est of $65.3M
23-08-07
MT
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Posts Q2 EPS $0.00, vs. Street Est of $-0.03
23-08-07
MT
Tactile Systems Technology, Inc. Revises Earnings Guidance for the Full Year 2023
23-08-07
CI
Tactile Systems Technology, Inc. Announces Senior Vice President of Sales Changes
23-07-18
CI
Tactile Systems Technology, Inc.(NasdaqGM:TCMD) dropped from Russell Microcap Value Index
23-06-23
CI
Tactile Systems Technology, Inc.(NasdaqGM:TCMD) dropped from Russell 3000E Value Index
23-06-23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
More about the company
Last Close Price
13.65
USD
Average target price
20.67
USD
Spread / Average Target
+51.40%
Consensus
1st Jan change
Capi.
-4.55% 324M +73.10% 12.38B -19.92% 7.81B +8.05% 6.72B +12.49% 5.39B +40.80% 5.03B -17.79% 4.72B -22.01% 4.06B -28.94% 2.68B +61.09% 2.59B
Medical Equipment
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1